CRP and cancer: Nevertheless, recurrence is observed in approximately 20% of patients following LT.3 Recently, various inflammatory markers such as neutrophil-to-lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), C-reactive protein (CRP), lymphocyte-to-monocyte ratio, and mean platelet volume (MPV) have been employed to assess immune responses in several diseases, including cancer.4 One recent study highlighted the crucial role of platelets in facilitating cancer metastasis.